Researchers have created a GeneTherapy that reverse damage to the heart inflicted by a heart attack by enabling heart cells to spread and renew, according to a study in pigs from ScienceTM.
Heart failure, a leading cause of death worldwide, is partly due to poor renewal capacity of adult heart muscle cells . Liuused gene therapy to knock down the endogenous Hippo signaling pathway in cardiomyocytes of adult pigs after myocardial infarction. Hippo pathway knockdown induced these cells to undergo self-limiting division, resulting in effective tissue renewal with improved heart function in treated pigs.
Here, we investigated an adeno-associated virus 9 –based gene therapy to locally knock down the Hippo pathway gene Salvador in border zone cardiomyocytes in a pig model of ischemia/reperfusion-induced myocardial infarction.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Moving Safely Through PTSD Recovery8 suggestions for how people can take care of themselves and manage difficult emotions while they work through their trauma, from shari_botwin
Lire la suite »
The Biggest Bombshells From Prince Harry in ‘The Me You Can’t See’ DocuseriesThe Duke of Sussex opens up about processing his mother’s death, starting therapy, and leaving the royal family with wife Meghan Markle.
Lire la suite »
Russia says Europe missing out on gas with Nord Stream 2 delayEurope, struggling with soaring gas prices, is missing out on additional Russian supplies amid delays to the Nord Stream 2 pipeline, a top Russian official signalled on Friday.
Lire la suite »
Kate Garraway’s husband Derek Draper reaches huge milestone in his recoveryDerek was hospitalised with Covid in March 2020 where he spent weeks in an induced coma and battled for his life. He has continued to recover throughout 2021 – and has been spotted outside with his family for the first time since his ordeal began.
Lire la suite »
Biogen, Eisai Alzheimer's drug lecanemab gets 'fast track' designation from FDABiogen Inc and Japanese partner Eisai Co said on Thursday the U.S. Food and Drug Administration (FDA) had granted 'fast track' designation to their experimental therapy lecanemab for the treatment of early Alzheimer's disease.
Lire la suite »